VBY329 — IND submission
H2 2026
We expect to advance VBY329 toward IND readiness in the second half of 2026.Source filing
IVVD biotech catalysts & pipeline
INVIVYD INC · Data as of 2026-09-08
Upcoming catalysts
VYD2311 — Topline data
Q3 2026
Invivyd continues to expect top-line data from the VYD2311 program around the end of Q3 2026.Source filing
VMS063 — IND submission
late 2026
Invivyd has begun Investigational New Drug (IND)-enablement and regulatory outreach to support rapid VMS063 development; goal is expedited development with target IND readiness in late 2026.Source filing
PEMGARDA (pemivibart) — Regulatory decision
Jun 29
Consequently, the EUA for PEMGARDA is set to terminate on June 29, 2027.Source filing